Nasdaq

WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA

WUXI, China, April 6, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully ...
Nasdaq

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

WUXI, China, Oct. 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP ...
Business Insider

WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection

SHANGHAI, March 27, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - announces that its new drug product manufacturing facility in Shanghai Pilot Free ...
Longview News-Journal

WuXi Biologics Again Passed GMP Inspection by Japan PMDA

WUXI, China, Feb. 26, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...
Hosted on MSN

FDA 510(K) Approved Facilities: Increasing GMP Inspections And Compliance Requirements

Indian medical device manufacturers are enhancing their Good Manufacturing Practice (GMP) compliance, reinforcing India's role as a trusted global supplier in the healthcare and MedTech sectors. This ...